Related Experiment Videos
Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
[Interactions between Tax of HTLV1 and cellular factors].
Virologie (Montrouge, France)·2023
Impact of the first wave of the COVID-19 pandemic on the treatment of psoriasis with systemic therapies in France: Results from the PSOBIOTEQ cohort.
Annales de dermatologie et de venereologie·2023
Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQ.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Children with psoriasis and COVID-19: factors associated with an unfavourable COVID-19 course, and the impact of infection on disease progression (Chi-PsoCov registry).
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort.
Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Pembrolizumab Plus Chemotherapy for HR+/HER2- PD-L1‒Positive Advanced Breast Cancer: Final Analysis of the Phase 3 KEYNOTE-B49 Study.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Atirmociclib and fulvestrant for patients with HR+/HER2- advanced/metastatic breast cancer who progressed on a prior cyclin-dependent kinase 4/6 inhibitor: primary analysis of the randomized FourLight-1 trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Adjuvant chemotherapy with cisplatin and gemcitabine compared to standard of care after curative intent resection of cholangiocarcinoma and muscle invasive gallbladder carcinoma (ACTICCA-1/AIO-HEP-0112 trial).
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Overall survival from the phase III postMONARCH trial of abemaciclib plus fulvestrant versus placebo plus fulvestrant for HR+, HER2- advanced breast cancer following progression on a prior CDK4/6 inhibitor plus endocrine therapy.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
A randomized Phase 1 study of telisotuzumab adizutecan (ABBV-400, Temab-A) in combination with bevacizumab versus trifluridine-tipiracil with bevacizumab in patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2026
Final results of nivolumab plus ipilimumab versus nivolumab or chemotherapy in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer from CheckMate 8HW.
Annals of oncology : official journal of the European Society for Medical Oncology·2026